Biggest News Aggregation in the World
📰 Deciphera Press News

Deciphera Press News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Deciphera Press. Real-time updates on events, politics, business and more.

Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

– QINLOCK Significantly Reduced the Risk of Disease Progression or Death by 85% and Showed Clinically Meaningful Overall Survival in the INVICTUS Phase 3 Study – ... | December 22, 2021
United Kingdom United States Hong Kong Steve Hoerter Deciphera Announces Health Canada Authorization Deciphera Announces Australian Therapeutic Goods Administration Approval

Deciphera Pharmaceuticals, Inc.: Deciphera Announces Approval of QINLOCK in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Seventh Approval Worldwide for QINLOCK and First European Approval - Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines
United States Hong Kong Jen Robinson David Rosen Steve Hoerter Deciphera Announces Australian Therapeutic Goods Administration Approval

Deciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Deciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor - read this article along with other careers information, tips and advice on BioSpace
United States Hong Kong Steve Hoerter Deciphera Announces Health Canada Authorization Deciphera Announces Australian Therapeutic Goods Administration Approval European Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science